This includes a £295,000 investment from Macmillan Cancer Support, further solidifying the charity’s belief in Perci Health’s mission to radically transform cancer care. Guinness Ventures and Conduit Fund have joined existing investors Octopus Ventures and 35 of the UK’s leading oncologists and cancer surgeons in backing Perci Health.

The new funds will support the company's ambitious plans to expand its AI-powered, multidisciplinary virtual cancer clinic, reaching more individuals and healthcare providers across the UK.

Founded by two passionate female healthcare innovators, Perci Health is redefining how cancer is managed, from prevention through to treatment and recovery. The company combines the latest technology with expert care from a multi-specialist team including nurses, dietitians, physiotherapists, psychologists and more, to create life changing outcomes for people impacted by cancer and their families.

“We’re incredibly impressed by the way Perci Health is tackling the gaps in cancer care with a human-first, tech-enabled model,” said Chantal Cox , Investor at Octopus Ventures. “This approach not only addresses pressing healthcare needs but also delivers measurable impact in terms of both clinical outcomes and cost-efficiency, which is vital for scaling the model across more insurers, employers, and health systems.”

Female leadership driving innovation

With 100% of directors, 80% of its leadership team and 60% of its executive board composed of women, Perci Health stands as one of the few UK scaleups with an all-female founding team. Despite the fact that less than 2% of venture capital goes to female-led teams, Perci Health has raised twice the average deal size for UK female-led startups in each of its funding rounds.

“Our mission to close the cancer care gap is powered by an outstanding team who are deeply committed to transforming the cancer care experience,” said Kelly McCabe, Co-Founder and CEO of Perci Health. “This investment will allow us to continue pioneering a model of care that integrates digital innovation with compassionate, specialist-led support, providing better outcomes for everyone living with and beyond cancer.”

Tackling the growing need for supportive cancer care

Macmillan estimates that there are currently almost 3.5 million people living with cancer in the UK and this number will continue to rise, creating an urgent need for new, effective ways to support patients. As more people are diagnosed with cancer at younger ages and survival rates improve, there is a growing population of working-age people who need ongoing support to stay in or return to work after treatment.

In the UK, cancer outcomes lag up to 25 years behind European peers, with 41% of staged diagnoses being at a late stage in England and around a third of eligible people missing critical screening appointments for breast, bowel and cervical cancer. Improving these outcomes will require collaboration across the government, NHS, private insurers, charities, and employers, and Perci Health’s model addresses these gaps by offering comprehensive care that spans prevention, early detection, treatment navigation, symptom management, and survivorship care.

“We know that cancer doesn’t stop when treatment ends. In fact, that’s often when people need the most support. Perci Health’s AI-driven platform ensures truly personalised care, enabling people to access the right support at the right time,” said Morgan Fitzsimons, Co-Founder and Chief Customer Officer.

Strategic partnerships fuel growth

The funds will also enable Perci Health to expand its partnerships with employers and insurers, ensuring that more people have access to its cancer care services. With over 4,000 members supported in 2024 alone and 2.5 million insurance lives covered, Perci Health has already demonstrated a 4x ROI for its insurance partners, with a 90 NPS score and a 4.8-star Trustpilot rating.

This investment comes at a pivotal moment, as the UK government increasingly prioritises vocational rehabilitation and reducing long-term sickness absence with the release of Labour’s “Keep Britain Working Review”. Perci Health supports these goals by enabling earlier intervention, personalised recovery plans, and return-to-work programmes that address both physical and psychological barriers, uniquely tailored to the complex needs of people with cancer. This approach aligns with Macmillan’s long-standing focus on work and cancer, raising awareness about the importance of employment in enhancing wellbeing and quality of life.

Perci’s model empowers working-age individuals living with and beyond cancer to regain their independence and financial stability, whilst delivering benefits not only for individuals and employers, but also contributing to national efforts to reduce economic inactivity due to ill health.

"At Guinness Ventures, we look for founders who are solving meaningful problems in an innovative way.” said Lisa Fox, Head of Co-Investment, Guinness Ventures.” Perci Health is doing exactly that in addressing one of the biggest and most underserved challenges in cancer care: how we support people after treatment ends. Their model combines clinical rigour with scalable technology, delivering meaningful outcomes not just for patients, but also for employers, insurers, and the broader healthcare ecosystem.”

“Supporting businesses that are developing scalable, meaningful impact in healthcare is a priority for us,” said Eva-Maria Dimitriadis, Managing Partner at Conduit Fund. “Perci Health’s innovative, patient-centric model, combined with its strong leadership and growth potential, is precisely the kind of forward-thinking solution that we want to help grow. As a female led business ourselves - with a majority female investment team – we know female founders statistically find it considerably more difficult to raise from VCs. We believe investing in female founders is not just the right thing to do, but it gives us access to exceptional opportunities that others overlook. 42% of companies we have invested in have at least one female founder and we are thrilled to add Perci Health to that list.”

“Cancer survivorship presents unique challenges, and we must innovate to meet the growing needs of people living with and beyond cancer.” said Claire Taylor, Chief Nursing Officer, Macmillan Cancer Support. “Perci Health’s holistic, multidisciplinary approach is exactly the exciting innovation that is needed, and it aligns perfectly with Macmillan’s ambitions to help more people get the personalised care they need. This partnership represents a shared commitment to making a real difference in the lives of those affected by cancer, helping people to live well and by providing tailored solutions to meet their changing needs following a cancer experience.”

A vision for the future

Perci Health’s ultimate goal is to radically improve global cancer outcomes by delivering Supportive Cancer Care through a digital, AI-native care model. With the number of people living with cancer set to rise dramatically, it’s essential to address long-term survivorship care needs with scalable, tech-enabled solutions that improve both patient outcomes and economic efficiency for health systems. With a rapidly expanding team of over 85 specialists, Perci Health is poised to lead the charge in ensuring that people living with cancer receive the holistic, specialised support they deserve.

“With more people living with cancer, there’s an urgent need for healthcare solutions that cater to long-term survivorship,” concludes McCabe. “By working with insurers, employers, and healthcare providers, we aim to reshape cancer care to ensure better outcomes for patients and cost savings for the system.”

For more startup news, check out the other articles on the website, and subscribe to the magazine for free. Listen to The Cereal Entrepreneur podcast for more interviews with entrepreneurs and big-hitters in the startup ecosystem.